Cardiac resynchronisation therapy in patients with heart failure and a normal QRS duration: The RESPOND study

Heart

Volumn 97, Issue 13, 2011, Pages 1041-1047

  Foley, Paul W X ^a   Patel, Kiran ^b   Irwin, Nick ^c   Sanderson, John E ^a   Frenneaux, Michael P ^a   Smith, Russell E A ^a   Stegemann, Berthold ^d   Leyva, Francisco ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b SANDWELL AND WEST BIRMINGHAM HOSPITALS NHS TRUST   (United Kingdom)

^c UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^d MEDTRONIC BAKKEN RESEARCH CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CHEMOTHERAPY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEMALE; FUNCTIONAL STATUS; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; QRS COMPLEX; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SURVIVAL TIME; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; CARDIAC RESYNCHRONIZATION THERAPY; ELECTROCARDIOGRAPHY; EPIDEMIOLOGIC METHODS; EXERCISE TEST; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; QUALITY OF LIFE; TREATMENT OUTCOME; WALKING;

EID: 79958019497     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2010.208355     Document Type: Article

References (48)

1. Cleland JG, Daubert JC, Erdmann E, et al. for the Cardiac Resynchronization-Heart Failure (CARE-HF) study investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-49. (Pubitemid 40517094)
2. Cazeau S, Leclercq C, Lavergene T, et al. Effects of multisite biventricular pacing in patients with heart failure and interventricular conduction delay. N Engl J Med 2001;344:873-80. (Pubitemid 32224395)
3. Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-53. (Pubitemid 34603028)
4. Bristow MR, Saxon LA, Boehmer J, et al. for the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac resynchronization therapy with or without an implantable defibrillator in advanced heart failure. N Engl J Med 2004;350:2140-50.
5. Bleeker GA, Schalij MJ, Molhoek SG, et al. Relationship between QRS duration and left ventricular dyssynchrony in patients with end-stage heart failure. J Cardiovasc Electrophysiol 2004;15:544-9. (Pubitemid 38621905)
6. Haghjoo M, Bagherzadeh A, Fazelifar A, et al. Prevalence of mechanical dyssynchrony in heart failure patients with different QRS durations. Pacing Clin Electrophysiol 2007;30:616-22. (Pubitemid 46656107)
7. Yu CM, Lin H, Zhang Q, et al. High prevalence of left ventricular systolic and diastolic asynchrony in patients with congestive heart failure and normal QRS duration. Heart 2003;89:54-60. (Pubitemid 36044290)
8. Kashani A, Barold SS. Significance of QRS complex duration in patients with heart failure. J Am Coll Cardiol 2005;46:2183-92. (Pubitemid 41785483)
9. Yu CM, Chan Y, Zhang Q, et al. Benefits of cardiac resynchronization therapy for heart failure patients with narrow QRS complexes and coexisting systolic asynchrony by echocardiography. J Am Coll Cardiol 2006;48:2251-7. (Pubitemid 44873057)
10. Achilli A, Sassara M, Ficili S, et al. Long-term effectiveness of cardiac resynchronization therapy in patients with refractory heart failure and "narrow" QRS. J Am Coll Cardiol 2003;42:2117-24. (Pubitemid 37549895)
11. Bleeker GB, Holman ER, Steendijk P, et al. Cardiac resynchronization therapy in patients with a narrow QRS complex. J Am Coll Cardiol 2006;48:2243-50. (Pubitemid 44873059)
12. Beshai J, Grimm R, Nagueh S, et al. Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. N Engl J Med 2007;357:2461-71. (Pubitemid 350272785)
13. Rector TS, Kubo SH, Cohn JN. Patient's self-assessment of their congestive heart failure. Content, reliability and validity of a new measure e the Minnesota Living with Heart Failure Questionnaire. Heart Failure 1987;3:198-207.
14. Ingle L, Shelton RJ, Rigby AS, et al. The reproducibility and sensitivity of the 6-min walk test in elderly patients with chronic heart failure. Eur Heart J 2005;26:1742-51. (Pubitemid 41219847)
15. Olsson LG, Swedberg K, Clark AL, et al. Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: a systematic review. Eur Heart J 2005;26:778-93. (Pubitemid 40547080)
16. Demers C, McKelvie RS, Negassa A, et al. Reliability, validity, and responsiveness of the six-minute walk test in patients with heart failure. Am Heart J 2001;142:698-703. (Pubitemid 32900498)
17. Solway S, Brooks D, Lacasse Y, et al. A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain. Chest 2001;119:256-70. (Pubitemid 32150576)
18. Barnett D, Phillips S, Longson C. Cardiac resynchronisation therapy for the treatment of heart failure: NICE technology appraisal guidance. Heart 2007;93:1134-5. (Pubitemid 47310998)
19. National Institute for Health and Clinical Excellence. Implantable cardioverter defibrillators fro arrhythmias. London: Review of Techonology Appraisal 11, 2007.
20. Alpert JS, Thygesen K, Antman E, et al. Myocardial infarction redefinedea consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:959-69.
21. Assomull RG, Prasad SK, Lyne J, et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 2006;48:1977-85. (Pubitemid 44738448)
22. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-7.
23. Myerburg RJ, Castellanos A. Cardiac arrest and sudden cardiac death. In: Braunwald E, ed. Heart disease: a textbook of cardiovascular medicine. New York: WB Saunders Publishing Co 1997:742-79.
24. Rockman HA, Juneau C, Chatterjee K, et al. Long-term predictors of sudden and low output death in chronic congestive heart failure secondary to coronary artery disease. Am J Cardiol 1989;64:1344-8. (Pubitemid 20000087)
25. Chalil S, Foley P, Muyhaldeen S, et al. Late gadolinium enhancement-cardiovascular magnetic resonance as a predictor of response to cardiac resynchronization therapy in patients with ischaemic cardiomyopathy. Europace 2007;9:1031-7. (Pubitemid 351773274)
26. Adelstein EC, Saba S. Scar burden by myocardial perfusion imaging predicts echocardiographic response to cardiac resynchronization therapy in ischemic cardiomyopathy. Am Heart J 2007;153:105-12. (Pubitemid 44880886)
27. Albertsen AE, Nielsen JC, Pedersen AK, et al. Left ventricular lead performance in cardiac resynchronization therapy: impact of lead localization and complications. Pacing Clin Electrophysiol 2005;28:483-8. (Pubitemid 40847496)
28. Chung E, Leon A, Tavazzi L, et al. Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation 2008;117:2608-16.
29. Pitzalis MV, Iacoviello M, Romito R, et al. Cardiac resynchronization therapy tailored by echocardiographic evaluation of ventricular asynchrony. J Am Coll Cardiol 2002;40:1615-22. (Pubitemid 35253639)
30. Khadjooi K, Foley P, Chalil S, et al. Long-term effects of cardiac resynchronisation therapy in patients with atrial fibrillation. Heart 2008;94:879-83. (Pubitemid 351914698)
31. Takemoto Y, Hozumi T, Sugioka K, et al. Beta-blocker therapy induces ventricular resynchronization in dilated cardiomyopathy with narrow QRS complex. J Am Coll Cardiol 2007;49:778-83. (Pubitemid 46242184)
32. Marcassa C, Campini R, Verna E, et al. Assessment of cardiac asynchrony by radionuclide phase analysis: correlation with ventricular function in patients with narrow or prolonged QRS interval. Eur J Heart Fail 2007;9:484-90. (Pubitemid 46561491)
33. Chalil S, Stegemann B, Muhyaldeen S, et al. Intraventricular dyssynchrony predicts mortality and morbidity following cardiac resynchronization therapy: a study using cardiovascular magnetic resonance tissue synchronization imaging. J Am Coll Cardiol 2007;50:243-52. (Pubitemid 47033969)
34. Foley PW, Khadjooi K, Ward JA, et al. Radial dyssynchrony assessed by cardiovascular magnetic resonance in relation to left ventricular function, myocardial scarring and QRS duration in patients with heart failure. J Cardiovasc Magn Reson 2009;11:50-6.
35. Williams LK, Ellery S, Patel K, et al. Short-term hemodynamic effects of cardiac resynchronization therapy in patients with heart failure, a narrow QRS duration, and no dyssynchrony. Circulation 2009;120:1687-94. CIRCULATIONAHA.108.799395.
36. Wilson JR, Rayos G, Yeoh TK, et al. Dissociation between exertional symptoms and circulatory function in patients with heart failure. Circulation 1995;92:47-53.
37. Abraham WT, Young JB, Leon AR, et al. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter- defibrillator, and mildly symptomatic chronic heart failure. Circulation 2004;110:2864-8. (Pubitemid 39473610)
38. Yu CM, Bleeker GB, Fung JW, et al. Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy. Circulation 2005;112:1580-6. (Pubitemid 41324519)
39. Ypenburg C, van Bommel RJ, Borleffs CJ, et al. Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up. J Am Coll Cardiol 2009;53:483-90.
40. Lafitte S, Reant P, Zaroui A, et al. Validation of an echocardiographic multiparametric strategy to increase responders patients after cardiac resynchronization: a multicentre study. Eur Heart J 2009;30:2880-7.
41. Bleasdale RA, Turner MS, Mumford CE, et al. Left ventricular pacing minimizes diastolic ventricular interaction, allowing improved preload-dependent systolic performance. Circulation 2004;110:2395-400. (Pubitemid 39407345)
42. Ypenburg C, Lancellotti P, Tops LF, et al. Acute effects of initiation and withdrawal of cardiac resynchronization therapy on papillary muscle dyssynchrony and mitral regurgitation. J Am Coll Cardiol 2007;50:2071-7. (Pubitemid 350087580)
43. Sadeghpour A, Abtahi F, Kiavar M, et al. Echocardiographic evaluation of mitral geometry in functional mitral regurgitation. J Cardiothorac Surg 2008;3:54.
44. Chalil S, Stegemann B, Muhyaldeen S, et al. Effect of posterolateral left ventricular scar on mortality and morbidity following cardiac resynchronization therapy. Pacing Clin Electrophysiol 2007;10:1201-7.
45. Schwartzman D, Chang I, Michele JJ, et al. Electrical impedance properties of normal and chronically infarcted ventricular myocardium. J Interv Card Electrophysiol 1999;3:213-24.
46. Reddy VY, Wrobleski D, Houghtaling C, et al. Combined epicardial and endocardial electroanatomic mapping in a porcine model of healed myocardial infarction. Circulation 2003;107:3236-42. (Pubitemid 36793097)
47. Tedrow U, Maisel W, Epstein L, et al. Feasibility of adjusting paced left ventricular activation by manipulating stimulus strength. J Am Coll Cardiol 2004;44:2249-51.
48. Breithardt OA, Stellbrink C, Kramer AP, et al. Echocardiographic quantification of left ventricular asynchrony predicts an acute hemodynamic benefit of cardiac resynchronization therapy. J Am Coll Cardiol 2002;40:536-45. (Pubitemid 34833172)